| Inhaled biologics: from preclinical to product approval K Fathe, S Ferrati, D Moraga-Espinoza, A Yazdi, H DC Smyth Current pharmaceutical design 22 (17), 2501-2521, 2016 | 26 | 2016 |
| A modified USP induction port to characterize nasal spray plume geometry and predict turbinate deposition under flow D Moraga-Espinoza, Z Warnken, A Moore, RO Williams III, HDC Smyth International journal of pharmaceutics 548 (1), 305-313, 2018 | 23 | 2018 |
| In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa F Tewes, TF Bahamondez-Canas, D Moraga-Espinoza, HDC Smyth, ... European Journal of Pharmaceutics and Biopharmaceutics 152, 210-217, 2020 | 11 | 2020 |
| Mass Median Plume Angle: A novel approach to characterize plume geometry in solution based pMDIs D Moraga-Espinoza, E Eshaghian, HDC Smyth International Journal of Pharmaceutics 543 (1-2), 376-385, 2018 | 10 | 2018 |
| The forgotten material: Highly dispersible and swellable gelatin-based microspheres for pulmonary drug delivery of cromolyn sodium and ipratropium bromide B Behrend-Keim, A Castro-Muñoz, L Monrreal-Ortega, B Ávalos-León, ... International Journal of Pharmaceutics 644, 123331, 2023 | 8 | 2023 |
| Overview of the delivery technologies for inhalation aerosols DF Moraga-Espinoza, AD Brunaugh, S Ferrati, LA Heersema, MJ Herpin, ... Inhalation Aerosols, 123-143, 2019 | 6 | 2019 |
| Modified release solid oral dosage forms AD Brunaugh, D Moraga-Espinoza, T Bahamondez-Canas, HDC Smyth, ... Essential pharmaceutics, 73-89, 2024 | 5 | 2024 |
| Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process J Gallegos-Catalán, Z Warnken, TF Bahamondez-Canas, ... Pharmaceutics 13 (7), 1051, 2021 | 5 | 2021 |
| Effect of inhalation flow rate on mass-based plume geometry of commercially available suspension pMDIs DF Moraga-Espinoza, E Eshaghian, A Shaver, HDC Smyth The AAPS Journal 20, 1-12, 2018 | 5 | 2018 |
| Formulation of water-soluble Buddleja globosa Hope extracts and characterization of their antimicrobial properties against Pseudomonas aeruginosa N Araya, MA Leiva-Soto, MV Bruna, A Castro-Munoz, B Behrend-Keim, ... Frontiers in Pharmacology 13, 921511, 2022 | 4 | 2022 |
| Development, characterization, and in vitro testing of Co-delivered antimicrobial dry powder formulation for the treatment of Pseudomonas aeruginosa biofilms TF Bahamondez-Canas, S Ferrati, DF Moraga-Espinoza, HDC Smyth Journal of Pharmaceutical Sciences 107 (8), 2172-2178, 2018 | 4 | 2018 |
| Nasal drug delivery AD Brunaugh, D Moraga-Espinoza, T Bahamondez-Canas, HDC Smyth, ... Essential Pharmaceutics, 215-220, 2024 | 3 | 2024 |
| Ophthalmic and otic drug delivery AD Brunaugh, D Moraga-Espinoza, T Bahamondez-Canas, HDC Smyth, ... Essential pharmaceutics, 141-149, 2024 | 3 | 2024 |
| Abstracts: International Society for Aerosols in Medicine eV 21st ISAM Congress Santa Fe, NM June 3–7, 2017 YM Madney, M Fathy, AA Elberry J Aerosol Med Pulm Drug Delivery 30 (3), A-1-A-38, 2017 | 3 | 2017 |
| Disperse Systems: Suspensions AD Brunaugh, D Moraga-Espinoza, T Bahamondez-Canas, HDC Smyth, ... Essential Pharmaceutics, 109-129, 2024 | 2 | 2024 |
| Essential Pharmaceutics in the Flipped Classroom AD Brunaugh, D Moraga-Espinoza, T Bahamondez-Canas, HDC Smyth, ... Essential Pharmaceutics, 1-11, 2024 | 1 | 2024 |
| Capsule and Tablet Dosage Forms AD Brunaugh, D Moraga-Espinoza, T Bahamondez-Canas, HDC Smyth, ... Essential Pharmaceutics, 47-72, 2024 | 1 | 2024 |
| Evaluating the creaming process in co-suspension based pressurized metered dose inhaler formulations by shadow tracking and image analysis D Moraga-Espinoza, P Tan, K Hansen, S Hoe, G Li, ... Proceedings of Drug Delivery to the Lungs 30, 2019 | 1 | 2019 |
| Preformulation in Drug Product Design AD Brunaugh, D Moraga-Espinoza, T Bahamondez-Canas, HDC Smyth, ... Essential Pharmaceutics, 23-46, 2024 | | 2024 |
| Solution-Based Dosage Forms and Sterile Products AD Brunaugh, D Moraga-Espinoza, T Bahamondez-Canas, HDC Smyth, ... Essential Pharmaceutics, 91-107, 2024 | | 2024 |
